180 related articles for article (PubMed ID: 20576283)
1. Micro-RNA-181a regulates osteopontin-dependent metastatic function in hepatocellular cancer cell lines.
Bhattacharya SD; Garrison J; Guo H; Mi Z; Markovic J; Kim VM; Kuo PC
Surgery; 2010 Aug; 148(2):291-7. PubMed ID: 20576283
[TBL] [Abstract][Full Text] [Related]
2. RNA stability regulates differential expression of the metastasis protein, osteopontin, in hepatocellular cancer.
Emani S; Zhang J; Guo L; Guo H; Kuo PC
Surgery; 2008 Jun; 143(6):803-12. PubMed ID: 18549897
[TBL] [Abstract][Full Text] [Related]
3. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
[TBL] [Abstract][Full Text] [Related]
4. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].
Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482
[TBL] [Abstract][Full Text] [Related]
5. An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma.
Takafuji V; Forgues M; Unsworth E; Goldsmith P; Wang XW
Oncogene; 2007 Sep; 26(44):6361-71. PubMed ID: 17452979
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor c-Myb promotes the invasion of hepatocellular carcinoma cells via increasing osteopontin expression.
Chen RX; Xia YH; Xue TC; Ye SL
J Exp Clin Cancer Res; 2010 Dec; 29(1):172. PubMed ID: 21190594
[TBL] [Abstract][Full Text] [Related]
7. MiR-181a Promotes Apoptosis and Reduces Cisplatin Resistance by Inhibiting Osteopontin in Cervical Cancer Cells.
Xu X; Jiang X; Chen L; Zhao Y; Huang Z; Zhou H; Shi M
Cancer Biother Radiopharm; 2019 Nov; 34(9):559-565. PubMed ID: 31436472
[No Abstract] [Full Text] [Related]
8. Segment-specific targeting via RNA interference mediates down-regulation of OPN expression in hepatocellular carcinoma cells.
Lin F; Huang CM; Cao J; Pei ZH; Gu WL; Fan SF; Li KP; Lin CM
Genet Mol Res; 2015 Nov; 14(4):14440-7. PubMed ID: 26600502
[TBL] [Abstract][Full Text] [Related]
9. Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells.
Cheng J; Huo DH; Kuang DM; Yang J; Zheng L; Zhuang SM
Cancer Res; 2007 Jun; 67(11):5141-7. PubMed ID: 17545592
[TBL] [Abstract][Full Text] [Related]
10. Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.
Zapf MA; Kothari AN; Weber CE; Arffa ML; Wai PY; Driver J; Gupta GN; Kuo PC; Mi Z
Surgery; 2015 Oct; 158(4):1039-47; discussion 1047-8. PubMed ID: 26189955
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of osteopontin in hepatocellular carcinoma and its relationships with metastasis, invasion of tumor cells.
Lin F; Li Y; Cao J; Fan S; Wen J; Zhu G; Du H; Liang Y
Mol Biol Rep; 2011 Nov; 38(8):5205-10. PubMed ID: 21188534
[TBL] [Abstract][Full Text] [Related]
12. miR-211 suppresses hepatocellular carcinoma by downregulating SATB2.
Jiang G; Cui Y; Yu X; Wu Z; Ding G; Cao L
Oncotarget; 2015 Apr; 6(11):9457-66. PubMed ID: 25888635
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-127-5p regulates osteopontin expression and osteopontin-mediated proliferation of human chondrocytes.
Tu M; Li Y; Zeng C; Deng Z; Gao S; Xiao W; Luo W; Jiang W; Li L; Lei G
Sci Rep; 2016 Apr; 6():25032. PubMed ID: 27126955
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.
Meng F; Henson R; Wehbe-Janek H; Ghoshal K; Jacob ST; Patel T
Gastroenterology; 2007 Aug; 133(2):647-58. PubMed ID: 17681183
[TBL] [Abstract][Full Text] [Related]
15. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
Qin AD; Liu XX; Li J; Liu J; Li YS
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
[No Abstract] [Full Text] [Related]
16. C-C chemokine receptor type 1 mediates osteopontin-promoted metastasis in hepatocellular carcinoma.
Zhu Y; Gao XM; Yang J; Xu D; Zhang Y; Lu M; Zhang Z; Sheng YY; Li JH; Yu XX; Zheng Y; Dong QZ; Qin LX
Cancer Sci; 2018 Mar; 109(3):710-723. PubMed ID: 29285854
[TBL] [Abstract][Full Text] [Related]
17. EF1A1-actin interactions alter mRNA stability to determine differential osteopontin expression in HepG2 and Hep3B cells.
Zhang J; Guo H; Mi Z; Gao C; Bhattacharya S; Li J; Kuo PC
Exp Cell Res; 2009 Jan; 315(2):304-12. PubMed ID: 19026636
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
Desai B; Rogers MJ; Chellaiah MA
Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
[TBL] [Abstract][Full Text] [Related]
19. MiR-1297 promotes apoptosis and inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting HMGA2.
Liu Y; Liang H; Jiang X
Int J Mol Med; 2015 Nov; 36(5):1345-52. PubMed ID: 26398017
[TBL] [Abstract][Full Text] [Related]
20. miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.
El Tayebi HM; Hosny KA; Esmat G; Breuhahn K; Abdelaziz AI
FEBS Lett; 2012 Sep; 586(19):3309-16. PubMed ID: 22819824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
